Trial Profile
A multicenter, single arm, phase II clinical trial of pimecrolimus administered topically to patients with Stages Ia-IIa mycosis fungoides.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2014
Price :
$35
*
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Mycosis fungoides
- Focus Therapeutic Use
- Acronyms Study PimTo-MF
- 26 Jul 2014 New trial record
- 26 Jul 2014 New trial record